Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
1.060
0.00 (0.00%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Predictive Oncology Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Predictive Oncology.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Predictive Oncology is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +183.02% | Aug 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +9,333.96% | Jun 30, 2021 |
Financial Forecast
Revenue This Year
9.52M
from 1.62M
Increased by 486.27%
Revenue Next Year
15.76M
from 9.52M
Increased by 65.50%
EPS This Year
-0.13
from -2.32
EPS Next Year
0.08
from -0.13
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 9.8M | 16.2M | 25.2M |
Avg | 9.5M | 15.8M | 24.4M |
Low | 9.1M | 15.1M | 23.5M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 503.5% | 70.4% | 59.7% |
Avg | 486.3% | 65.5% | 55.2% |
Low | 463.2% | 59.0% | 49.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.14 | 0.08 | 0.28 |
Avg | -0.13 | 0.08 | 0.28 |
Low | -0.13 | 0.08 | 0.26 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | 247.4% |
Avg | - | - | 237.5% |
Low | - | - | 224.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.